Compare OPHC & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPHC | BTMD |
|---|---|---|
| Founded | 2000 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.5M | 65.8M |
| IPO Year | 2012 | 2021 |
| Metric | OPHC | BTMD |
|---|---|---|
| Price | $7.58 | $2.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $6.50 | $2.83 |
| AVG Volume (30 Days) | 73.2K | ★ 204.5K |
| Earning Date | 04-24-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | ★ 0.20 | 0.06 |
| Revenue | N/A | ★ $192,219,000.00 |
| Revenue This Year | $17,095.98 | $2.03 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | ★ $35.25 | $37.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.91 | $1.27 |
| 52 Week High | $7.35 | $4.20 |
| Indicator | OPHC | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 82.90 | 50.47 |
| Support Level | $5.33 | $1.99 |
| Resistance Level | N/A | $2.49 |
| Average True Range (ATR) | 0.24 | 0.18 |
| MACD | 0.13 | -0.02 |
| Stochastic Oscillator | 95.54 | 43.55 |
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. The services provided by the bank include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, borrowings, repayment of loans, money market deposit accounts, debit cards, automated teller machines, and other bank related services.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.